×
Volver a Agenda
Session 5 Track 2: How Generative AI is Transforming Medical Writing
Session Chair(s)
Nimita Limaye, PHD
Research VP, Life Sciences R&D Strategy and Technology, at IDC, IDC, United States
This session will discuss how technology players, CROs, and life sciences companies are leveraging AI/GenAI to transform Medical Writing. It will discuss the key use cases that are being implemented, examine the ROI that can be generated, dig into some of the implementation challenges, explore regulatory considerations, change management issues, and how GenAI will completely transform medical writing operations over time.
Learning Objective : - Discuss which are the use cases that show promise for the implementation of GenAI in Medical Writing
- Describe how to address some of the implementation challenges related to leveraging GenAI in Medical Writing
- Identify how new business models for medical writing will be structured
- Recognize the key strategies for driving and scaling adoption of GenAI in Medical Writing
Speaker(s)
Julia Forjanic Klapproth, PHD
Senior Partner, Trilogy Writing & Consulting GmbH, Germany
Speaker
James Wolfe, PHD, MS
Vice President, Medical Writing Services, PAREXEL, France
Speaker
Erica Cave, PHD, MSC
Director, Medical Communications Writing, IQVIA, United Kingdom
Speaker
¿Tiene una cuenta?